** Shares of drugmaker AbbVie ABBV.N rise 3.5% to $196 premarket
** AbbVie raises its annual adj. profit per share to between $11.88 and $12.08, from previous expectations of $11.67 to $11.87
** Company earned quarterly profit per share of $2.97 compared with analysts' average estimates of $2.88 per share - data compiled by LSEG
** AbbVie's second-quarter revenue came in at $15.42 billion vs estimate of $15.03 billion
** Skyrizi recorded Q2 sales of $4.42 billion, beating estimates of $4 billion while Rinvoq sales of $2.03 billion topped estimates of $1.97 billion
** Up to last close, stock up 6.5% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。